APA (7th ed.) Citation

M, R., M, C., R, F., PY, D., G, P., D, L., . . . G, L. (2026). Lipid Nanoparticle-Mediated Delivery of 27-Hydroxycholesterol for Targeting Rhinovirus-Induced Respiratory Diseases. Molecular pharmaceutics, 23(4), 2362. https://doi.org/10.1021/acs.molpharmaceut.5c01299

Chicago Style (17th ed.) Citation

M, Repellin, Costantino M, Francese R, Dugas PY, Poli G, Lembo D, Civra A, and Lollo G. "Lipid Nanoparticle-Mediated Delivery of 27-Hydroxycholesterol for Targeting Rhinovirus-Induced Respiratory Diseases." Molecular Pharmaceutics 23, no. 4 (2026): 2362. https://doi.org/10.1021/acs.molpharmaceut.5c01299.

MLA (9th ed.) Citation

M, Repellin, et al. "Lipid Nanoparticle-Mediated Delivery of 27-Hydroxycholesterol for Targeting Rhinovirus-Induced Respiratory Diseases." Molecular Pharmaceutics, vol. 23, no. 4, 2026, p. 2362, https://doi.org/10.1021/acs.molpharmaceut.5c01299.